HTG Molecular Diagnostics Statistics
Total Valuation
HTGMQ has a market cap or net worth of $3,321.
| Market Cap | 3,321 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HTGMQ has 2.21 million shares outstanding.
| Shares Outstanding | 2.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.00% |
| Owned by Institutions (%) | n/a |
| Float | 2.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| Forward PS | 0.00 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -54.06 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $65,506 |
| Profits Per Employee | -$183,913 |
| Employee Count | 53 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HTGMQ has paid $6,217 in taxes.
| Income Tax | 6,217 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.96% in the last 52 weeks. The beta is 2.98, so HTGMQ's price volatility has been higher than the market average.
| Beta (1Y) | 2.98 |
| 52-Week Price Change | -99.96% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 43.79 |
| Average Volume (30 Days) | 1,550 |
Short Selling Information
The latest short interest is 2,726, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 2,726 |
| Short Previous Month | 51,273 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, HTGMQ had revenue of $3.47 million and -$9.75 million in losses. Loss per share was -$4.40.
| Revenue | 3.47M |
| Gross Profit | 290,453 |
| Operating Income | -9.56M |
| Pretax Income | -9.74M |
| Net Income | -9.75M |
| EBITDA | -9.43M |
| EBIT | -9.62M |
| Loss Per Share | -$4.40 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity / Book Value | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -$6.39 million and capital expenditures -$6,239, giving a free cash flow of -$6.39 million.
| Operating Cash Flow | -6.39M |
| Capital Expenditures | -6,239 |
| Free Cash Flow | -6.39M |
| FCF Per Share | -$2.89 |
Margins
Gross margin is 8.37%, with operating and profit margins of -275.45% and -280.76%.
| Gross Margin | 8.37% |
| Operating Margin | -275.45% |
| Pretax Margin | -280.58% |
| Profit Margin | -280.76% |
| EBITDA Margin | -271.70% |
| EBIT Margin | -277.06% |
| FCF Margin | -184.14% |
Dividends & Yields
HTGMQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -293,507.14% |
| FCF Yield | -192,503.04% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 21, 2022. It was a reverse split with a ratio of 1:12.
| Last Split Date | Dec 21, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |